Skip to main content

RETRACTION article

Front. Physiol., 04 August 2022
Sec. Mitochondrial Research
This article is part of the Research Topic Role of Mitochondrial Quality Control in Myocardial and Microvascular Physiology and Pathophysiology View all 43 articles

Retraction: Mammalian STE20-like kinase 2 promotes lipopolysaccharides-mediated cardiomyocyte inflammation and apoptosis by enhancing mitochondrial fission

A Retraction of the Original Research article
Mammalian STE20-like kinase 2 promotes lipopolysaccharides-mediated cardiomyocyte inflammation and apoptosis by enhancing mitochondrial fission

by Tian, Y., Song, H., Qin, W., Ding, Z., Zhang, Y., Shan, W., and Jin, D. (2020). Front. Physiol. 11:897. doi: 10.3389/fphys.2020.00897

The Publisher retracts the cited article.

Following publication, the publisher uncovered evidence that false identities were used in the peer-review process. The assignment of a fake reviewer was confirmed by an investigation, conducted in accordance with Frontiers’ policies and the Committee on Publication Ethics (COPE) guidelines.

The investigation also uncovered concerns about the presentation and validity of the data in the article that normally would have led to a rejection. When contacted, the authors failed to provide a data set that adequately supports the reported conclusions.

The authors do not agree to this retraction.

This retraction was approved by the Chief Editors of Frontiers in Physiology and the Chief Executive Editor of Frontiers.

Citation: Frontiers Editorial Office (2022) Retraction: Mammalian STE20-like kinase 2 promotes lipopolysaccharides-mediated cardiomyocyte inflammation and apoptosis by enhancing mitochondrial fission. Front. Physiol. 13:1006549. doi: 10.3389/fphys.2022.1006549

Received: 29 July 2022; Accepted: 02 August 2022;
Published: 04 August 2022.

Approved by:

John D. Imig, Medical College of Wisconsin, United States

Copyright © 2022 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, ZWRpdG9yaWFsLm9mZmljZUBmcm9udGllcnNpbi5vcmc=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.